| (210) | Number of the EPO application | 19818401 |
| (220) | Filing date of the EPO application | 2019.11.18 |
| (80) | EPO patent specification publication (B) | EPB nr. 52/2021, 2021.12.29 |
| (110) | EPO patent number | 3880654 |
| (11) | Number of the document | MD 3880654 T2 |
| (21) | Number of the application | e 2021 0907 |
| (71) | Name(s) of applicant(s), code of the country | Global Blood Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LI Zhe, US; |
| (73) | Name(s) of owner(s), code of the country | Global Blood Therapeutics, Inc., US; |
| (54) | Title of the invention | 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 207/08 (2006.01.01); C07D 211/22 (2006.01.01); C07D 265/30 (2006.01.01); C07D 279/12 (2006.01.01); C07D 401/06 (2006.01.01); C07D 401/10 (2006.01.01); C07D 403/06 (2006.01.01); C07D 413/06 (2006.01.01); C07D 417/06 (2006.01.01); A61P 7/06 (2006.01.01); A61K 31/40 (2006.01.01); A61K 31/4427 (2006.01.01); A61K 31/445 (2006.01.01); A61K 31/4523 (2006.01.01); A61K 31/497 (2006.01.01); A61K 31/5375 (2006.01.01); A61K 31/5377 (2006.01.01); A61K 31/54 (2006.01.01); A61K 31/541 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.10.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.05.31 |
| (30) | Priority | 201862769196 P, 2018.11.19, US; 201962821314 P, 2019.03.20, US; 201962848773 P, 2019.05.16, US; 201962883313 P, 2019.08.06, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2019/062054, 2019.11.18 |
| (87) | International publication | WO 2020/106642, 2020.05.28 |